These results suggest a crosstalk between adipose tissue and the bone, as endocrine organs, and indicate that FGF-23, osteopontin and NGAL may serve as biomarkers of obesity and its pathophysiologic implications, such as insulin resistance. This evidence concerns the gene LCN2 and obesity disorder.